With our latest research in #LungCancer, we’re advancing new options for patients and improving their treatment experience. We look forward to sharing new data on our targeted therapy for patients with #NSCLC at #WCLC24: t.co/qi8l8tyQoC #JNJOncology t.co/t0eviy1rzj